AMD Risk Not Tied to Long-Term Metformin Use
Drug Topics
JANUARY 4, 2023
The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
Drug Topics
JANUARY 4, 2023
The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
STAT
JANUARY 4, 2023
Pregnancy, for the average person, is an exercise of extremes — swelling body, welling emotions, surging hormones. For people with chronic conditions and other disabilities, the experience can be even more jarring, full of additional barriers, stigma, and risks. But it’s not just pregnancy. In the United States, disabled people are less likely to be taught comprehensive sexual education and given access to contraceptives, and are more likely to have unintended pregnancies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 4, 2023
Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.
Pharmacy Times
JANUARY 4, 2023
The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JANUARY 4, 2023
Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.
Pharmacy Times
JANUARY 4, 2023
The dual-action cell therapy is designed to eliminate established tumors, train the immune system to eradicate a primary tumor, and prevent recurrence.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JANUARY 4, 2023
The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.
Drug Topics
JANUARY 4, 2023
Researchers speculate that the disparities among those with private insurance coverage may reflect differences in overcoming hurdles to access, such as prior authorization.
Pharmacy Times
JANUARY 4, 2023
Pharmacists play a vital role in administering these and educating patients about COVID-19, influenza, pneumococcal, and Tdap vaccinations.
STAT
JANUARY 4, 2023
Walgreens plans to seek certification to begin providing abortion pills under new Food and Drug Administration rules that allow the drugs to be distributed by retail pharmacies, the company told STAT on Wednesday. “We are working through the registration, necessary training of our pharmacists, as well as evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements and will dispense these consistent with federal and state laws,
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JANUARY 4, 2023
Mentorship is a long-term and formative process and interaction that extends beyond initial discussions regarding the mentee's career path.
The Checkup by Singlecare
JANUARY 4, 2023
If you have Type 1 or Type 2 diabetes , your healthcare provider will recommend that you aim to stay within your target range, or normal range, as much as possible. Doing so is best for your overall health and helps you prevent or delay long-term complications of high blood sugar. . Hypoglycemia is the medical term for low blood glucose levels (or blood sugar levels).
Pharmacy Times
JANUARY 4, 2023
Children who experienced COVID-19-induced multisystem inflammatory syndrome did not experience severe adverse reactions following COVID-19 vaccination.
STAT
JANUARY 4, 2023
China is underreporting deaths from Covid-19, a senior official of the World Health Organization said Wednesday as he urged use of a broader definition that would more fully capture the mortality impact of the country’s first big wave of Covid infection. Mike Ryan, head of the WHO’s health emergencies program, stressed that doctors and nurses should not be discouraged from reporting Covid cases and deaths.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 4, 2023
A study showed that the risk of developing venous thromboembolism is worse for perimenopausal women with diabetes.
DiversifyRx
JANUARY 4, 2023
Pharmacy marketing is one of our favorite topics at DiversifyRx. Here are our top blogs to help you improve your pharmacy’s marketing. Last week we shared our Top 2022 Blog Resources To Optimize your PBM Revenue , which covers our third Pharmacy Profit Pillar PBM Optimization. This week we will dive into the most popular blogs from 2022 that focus on independent pharmacy marketing, our fourth Pharmacy Profit Pillar.
Pharmacy Times
JANUARY 4, 2023
The changes will almost certainly widen access for patients seeking medicated abortions in states without legal obstacles.
Hospital Pharmacy Europe
JANUARY 4, 2023
A comparative analysis with common viral infections suggests that many recognised post COVID-19 condition symptoms are not unique to the virus. According to the findings of an analysis by US researchers, only some of the post COVID-19 condition symptoms can be uniquely attributed to infection with the virus when compared to the post-infection symptoms induced by other, common viral infections.
Pharmacy Times
JANUARY 4, 2023
Greater prevalence of hand eczema among health care professionals working in COVID-19 units linked to increased hand sanitation habits.
pharmaphorum
JANUARY 4, 2023
More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic syndromes (MDS). The Foster City, California-based biotech said today that its IMerge trial of imetelstat – vying to become the first telomerase inhibitor to reach the market – hit its objectives in patients with lower risk MDS, a rare group of bone marrow cancers.
NF2 BioSolutions
JANUARY 4, 2023
We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE. Hold a cake sale and/or Coffee morning for this fundraiser.
European Pharmaceutical Review
JANUARY 4, 2023
EVOQ Therapeutics Inc has agreed to license its NanoDisc technology for rheumatoid arthritis (RA) and lupus to Gilead Sciences, Inc, enabling EVOQ to potentially receive up $658.5 million. The companies will collaborate to advance preclinical development and Gilead will be responsible for clinical development and commercialisation. “Despite key advances over the past two decades, there remains significant unmet need for people living with inflammatory and autoimmune diseases,” stated Dr Flavius
STAT
JANUARY 4, 2023
SACRAMENTO, Calif. (AP) — About 600 people alive today can’t have children because California’s government sterilized them either against their will or without their knowledge, and now the state is trying to find them so it can pay them at least $15,000 each in reparations. But after a year of searching, the state has approved just 51 people for payments out of 310 applications.
Fierce Pharma
JANUARY 4, 2023
Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report. esagonowsky. Wed, 01/04/2023 - 10:21.
The Checkup by Singlecare
JANUARY 4, 2023
A blood test for diabetes measures the amount of glucose or sugar in a person’s blood. Diabetes is a condition in which the body has trouble converting sugar from food into energy. It can be caused when there isn’t enough insulin or the insulin in the body is not working well enough to process sugar. This can lead to high blood sugar levels in the bloodstream, causing symptoms like increased thirst and frequent urination, among other complications, as the disease progresses. .
Drug Store News
JANUARY 4, 2023
As part of this year’s summit, Hy-Vee will work to identify suppliers with diverse backgrounds and is encouraging minority-owned and women-owned businesses to apply.
STAT
JANUARY 4, 2023
For the first two years of the Covid-19 pandemic, people working in the infectious diseases and global health spheres were largely focused on the new disease. In 2022, however, gears shifted. Covid didn’t go away, but diseases like flu that had been held in abeyance by the new virus and the measures we used to slow its spread — well, they’re baaack.
Drug Store News
JANUARY 4, 2023
The Consolidated Appropriations Act will increase competition from generic and biosimilar medicines and enhance patient access to lower cost prescription drugs.
STAT
JANUARY 4, 2023
The emergency department is often called a hospital’s front door. For many people desperate for reproductive care, it is being seen as their last chance. But these days, getting treatment for pregnancy-related medical emergencies in the emergency department is complicated. State abortion bans threaten access to emergency reproductive care by introducing complex legislative restrictions around what counts as a medical emergency.
pharmaphorum
JANUARY 4, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA), seeking approval of talquetamab for the treatment of patients with relapsed or refractory multiple myeloma (RRMM). Multiple myeloma is an incurable blood cancer that affects plasma cells, a type of white blood cells found in the bone marrow.
The Guardian - Pharmaceutical Industry
JANUARY 4, 2023
Pharmacy leaders cite ministers’ ‘lack of planning’ amid problems obtaining common products A shortage of cough and cold medicines in the UK is a result of ministers’ “lack of planning”, according to pharmacy leaders. Rishi Sunak’s Conservatives were accused of “being in denial” as supply chain problems worsen, with pharmacists reporting shortages of once-common cold and flu medicines.
pharmaphorum
JANUARY 4, 2023
Retail pharmacies in the US will be able to dispense mifepristone-based therapies to end pregnancies after the FDA introduced changes to its regulatory framework for the products. A change to the risk evaluation and mitigation strategy (REMS) for mifepristone – sold as Mifeprex by Danco Labs and also available as a generic – means that it no longer needs to be dispensed in person by a healthcare provider at a registered clinic.
PharmExec
JANUARY 4, 2023
Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.
Fierce Pharma
JANUARY 4, 2023
Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M. mbayer. Wed, 01/04/2023 - 06:37.
Let's personalize your content